|
|
||||||||
Division of Nuclear Medicine of the Department of Radiology and the Infectious Disease and Cardiac Units of the Medical Service of the Massachusetts General Hospital and the Departments of Radiology and Medicine, Harvard Medical School, Boston, Massachusetts
Ortho Biotech Imaging Products, Washingtons Crossing, New Jersey
Correspondence: For reprints contact: H. William Strauss, MD, Div. of Nuclear Medicine, Dept. of Radiology, Massachusetts General Hospital, 32 Fruit St., Boston, MA 02114.
ABSTRACT
The utility of nonspecific polyclonal IgG for external imaging of experimental atherosclerosis was tested in a series of rabbits after balloon catheter deendothelialization of the abdominal aorta. Following injection of 111In-IgG, 111In-Fc, or 111In-Fab serial images were recorded. In addition, several animals received 125I-low density lipoproteins [125I-LDL], or 125I human serum albumin [125I-HSA] as positive and negative controls. Forty-eight hours after injection of the radiolabeled proteins, the aortas were removed, divided into abdominal and thoracic regions, counted, and autoradiographed. The images acquired after injection of 111In-IgG and 111In-Fc, showed dear focal accumulation of radioactivity in the healing abdominal aorta. In contrast, the images obtained after injectionof 111In-Fab did not show focal radionuclide accumulation. For 111In-IgG and 111In-Fc there were three to six times as many counts in the abdominal as in the thoracic aorta, while for 111In-Fab and 125I HSA, the abdominal and thoracic counts were nearly equal. The results suggest that radiolabeled IgG and Fc can be used to image experimental atherosclerosis.
This article has been cited by other articles:
![]() |
M. P. S. Dunphy, H. Schoder, and H. W. Strauss Radionuclide Techniques for Identifying Vulnerable Plaque J. Nucl. Med., November 1, 2007; 48(11): 1753 - 1755. [Full Text] [PDF] |
||||
![]() |
S. Ben-Haim, E. Kupzov, A. Tamir, and O. Israel Evaluation of 18F-FDG Uptake and Arterial Wall Calcifications Using 18F-FDG PET/CT J. Nucl. Med., November 1, 2004; 45(11): 1816 - 1821. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iwasaki, T. Iwasaki, Y. Aihara, T. Kanda, N. Oriuchi, K. Endo, H. Katoh, T. Suzuki, and R. Nagai Immunoscintigraphy of Aortic Dissection with 99mTc-Labeled Murine Anti-Smooth Muscle Myosin Monoclonal Antibody in Rats J. Nucl. Med., January 1, 2001; 42(1): 130 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pasterkamp, E. Falk, H. Woutman, and C. Borst Techniques characterizing the coronary atherosclerotic plaque: influence on clinical decision making? J. Am. Coll. Cardiol., July 1, 2000; 36(1): 13 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsimikas, B. P. Shortal, J. L. Witztum, and W. Palinski In Vivo Uptake of Radiolabeled MDA2, an Oxidation-Specific Monoclonal Antibody, Provides an Accurate Measure of Atherosclerotic Lesions Rich in Oxidized LDL and Is Highly Sensitive to Their Regression Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 689 - 697. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Elmaleh, J. Narula, J. W. Babich, A. Petrov, A. J. Fischman, B.-A. Khaw, E. Rapaport, and P. C. Zamecnik Rapid noninvasive detection of experimental atherosclerotic lesions with novel 99mTc-labeled diadenosine tetraphosphates PNAS, January 20, 1998; 95(2): 691 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Narula, A. Petrov, C. Bianchi, C. C. Ditlow, B. C. Lister, J. Dilley, I. Pieslak, F. W. Chen, V. P. Torchilin, and B.-A. Khaw Noninvasive Localization of Experimental Atherosclerotic Lesions With Mouse/Human Chimeric Z2D3 F(ab')2 Specific for the Proliferating Smooth Muscle Cells of Human Atheroma : Imaging With Conventional and Negative Charge–Modified Antibody Fragments Circulation, August 1, 1995; 92(3): 474 - 484. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |